Jacob Hurst
Company: Etcembly
Job title: Chief Technology Officer & Co-Founder
Seminars:
Developing Ultraprecision T-Cell Receptor Bispecific Immunotherapies Using Generative AI 9:30 am
Leveraging the power of our Generative AI platform and proprietary screening system to deliver optimal TCRs Engineering TCRs through generative AI to produce optimal clinical candidatesRead more
day: Conference Day 1 - AM